Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. - Wikidata - wikimedia - TriplyDB

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.

http://www.wikidata.org/entity/Q45234671

about

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Multiple sclerosis: molecular mechanisms and therapeutic opportunities Mitochondrial glutathione, a key survival antioxidant.Superoxide anion, uncoupling proteins and Alzheimer's disease.Neuroprotective strategies involving ROS in Alzheimer disease.Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain.The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model.Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?Melatonin Therapy in Patients with Alzheimer's Disease.A delicate balance: Iron metabolism and diseases of the brain.Melatonin in Alzheimer's disease Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.Biometals and their therapeutic implications in Alzheimer's disease.Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.Nitrative Stress and Tau Accumulation in Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) in the Kii Peninsula, Japan.The Role of Free Radicals in Autophagy Regulation: Implications for Ageing.The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease.Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone.Fighting the Cause of Alzheimer's and GNE Myopathy Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration

P2860

Q26744105-E45D9AFC-6B7F-4AD1-B2A6-B2E5AD7EE9E6 Q26781496-83BC05A8-5736-464E-84B7-8CE675FDF331 Q26799258-F35129A5-083B-44A1-905E-0C930AF58F4A Q27009475-70DD2C85-6469-4C86-9578-8794B995ECCA Q27023735-00E74F36-F8BD-42E8-A814-3FA3C7A4264B Q33649876-BFFDCC64-EF52-4AA4-B5F1-FC95289A2CBD Q33858398-703FD86A-0BD9-4816-97C0-6C83B15FEECC Q34757939-C548BB1C-6C34-42DD-B7C3-FCB84300D2C0 Q35085261-19497C77-D31C-490A-8B1C-76056841A8C6 Q35800000-A0C4531C-6CDF-4CD1-99AF-1859940C7FEB Q35802867-40D3B630-2DC3-4E10-B756-7E2611AE3689 Q36241505-E8024C02-1566-4710-93BF-C7F47BB19C4E Q36335048-E1EF9E8C-F6B1-44BE-9133-0D66C2AC93A1 Q37023585-5CD1F93D-FE1F-4EA5-9AEB-A81C5DE9A66C Q37091982-7AEE57F7-3452-402C-9823-AE55AD934CA0 Q37384934-A74A2229-81C7-450E-B518-9A88E425D30B Q37725605-7C2D6446-B9FA-40E4-8353-F66C25EC1721 Q37893463-C3CF7673-694D-48CE-9B38-165E17988ADF Q38263669-F9106284-5410-464E-A3C3-0C7F11F7E062 Q38401306-8175BC40-DA88-47CD-BE50-A5F37575A841 Q38994300-17222982-61FE-44EE-BA1D-BABC774B8EA6 Q39205712-0D73D704-0F97-42D1-8D29-9BE1C05B1351 Q39281122-1C4927D8-884A-403F-ABDF-CFD48D9A3DDE Q45923792-B5FE1FEF-14EA-49C0-AFDB-8991AA5C5F12 Q47887763-95CB2FB1-452C-4185-8A69-5F5757AC7D4D Q49289702-687144BA-0559-4093-B33F-BAB6A9A17C22 Q52313112-67F02214-6F82-4133-9779-79C69864EF8A Q53396985-A730A58F-7DD8-4EE5-BF5A-B210A2473B71 Q54117292-4340844F-B816-4CB0-8CDA-B8634FFE0C43 Q58122164-8F6FFBB8-79DC-46E6-8262-228C83CF7D37 Q58769184-B63DCD2E-6D7B-45A6-8118-EA44020940D9

P2860

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.

http://www.wikidata.org/entity/Q45234671

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@en

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@nl

type

label

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@en

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@nl

prefLabel

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@en

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@nl

P1433

Q45234671-285C673B-B5FB-403C-926A-9DC6AE660360

P1476

Q45234671-47BC9642-5192-4010-BDB4-C2F47C69DD07

P2093

Q45234671-1936AE61-F04C-4D02-BAFF-DEEBFADDD0B6

Q45234671-2837567F-A541-4668-99A8-E63EDA78479B

Q45234671-A59F39E0-950C-4BD1-8733-DEA0CEAFC41C

Q45234671-B74E3CFB-2B8C-40D8-B113-05B51C7BB43F

Q45234671-F40EBE2A-E1A1-4CF7-93D2-78E3025D03F9

P304

Q45234671-B7E3289A-936F-4A24-B696-C0DF5EBB0B1D

P31

Q45234671-B33A91B2-158A-45DC-AB85-4E37B727B54B

P433

Q45234671-18BF3B66-E758-4C85-A6D0-32AF31236CFB

P478

Q45234671-B4FDDB11-1E62-4962-A6A2-6EAEAA3C7E4E

P577

Q45234671-BD027EC5-4B8B-4E6E-A852-32092C97AC38

P698

Q45234671-665FB306-8857-41F9-8B4D-125B9E292B06

P1433

Journal of Alzheimer's Disease

P1476

Induction of hyperphosphorylat ...... nd glycogen synthase kinase-3.

@en

P2093

Chengsong Xie

http://www.w3.org/2001/XMLSchema#string

Mark A Lovell

http://www.w3.org/2001/XMLSchema#string

Peter Davies

http://www.w3.org/2001/XMLSchema#string

Shuling Xiong

http://www.w3.org/2001/XMLSchema#string

William R Markesbery

http://www.w3.org/2001/XMLSchema#string

P304

659-71; discussion 673-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15665406

http://www.w3.org/2001/XMLSchema#string